Iveric Bio Announces Presentation of Post-Hoc Analysis at Macula Society from GATHER1 Clinical Trial of Zimura in Patients with Geographic Atrophy

10.06.2022 - IVERIC bio, Inc. (Nasdaq: ISEE) announced today a post-hoc analysis from the Zimura (avacincaptad pegol) GATHER1 clinical trial which explored enhanced Optical Coherence Tomography (OCT) image analysis to examine the effect of Zimura on change in ... Seite 1

Related Keywords

Iveric Bio ,Christopher Simms ,Justisp Ehlers ,Leona Campane Center ,Imaging Research ,Cole Eye Institute ,Chief Commercial Officer ,Image Guided Surgery ,Advanced Imaging Research ,